Milestone Scientific Inc. (MLSS)
Milestone Scientific Statistics
Share Statistics
Milestone Scientific has 78.38M shares outstanding. The number of shares has increased by 0.86% in one year.
| Shares Outstanding | 78.38M |
| Shares Change (YoY) | 0.86% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 5.55% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 174 |
| FTD / Avg. Volume | 0.23% |
Short Selling Information
The latest short interest is 146.15K, so 0.19% of the outstanding shares have been sold short.
| Short Interest | 146.15K |
| Short % of Shares Out | 0.19% |
| Short % of Float | 0.24% |
| Short Ratio (days to cover) | 3 |
Valuation Ratios
The PE ratio is -16.25 and the forward PE ratio is -23.62. Milestone Scientific's PEG ratio is 0.44.
| PE Ratio | -16.25 |
| Forward PE | -23.62 |
| PS Ratio | 11.9 |
| Forward PS | 6.5 |
| PB Ratio | 13.13 |
| P/FCF Ratio | -26.23 |
| PEG Ratio | 0.44 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Milestone Scientific.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.48, with a Debt / Equity ratio of 0.06.
| Current Ratio | 2.48 |
| Quick Ratio | 1.49 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | -0.05 |
| Debt / FCF | -0.12 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $378,505.18 |
| Profits Per Employee | $-277,270.41 |
| Employee Count | 17 |
| Asset Turnover | 0.66 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 58.05% in the last 52 weeks. The beta is 1.12, so Milestone Scientific's price volatility has been higher than the market average.
| Beta | 1.12 |
| 52-Week Price Change | 58.05% |
| 50-Day Moving Average | 0.96 |
| 200-Day Moving Average | 0.96 |
| Relative Strength Index (RSI) | 61.93 |
| Average Volume (20 Days) | 74,331 |
Income Statement
In the last 12 months, Milestone Scientific had revenue of 6.43M and earned -4.71M in profits. Earnings per share was -0.06.
| Revenue | 6.43M |
| Gross Profit | 6.43M |
| Operating Income | -6.76M |
| Net Income | -4.71M |
| EBITDA | -6.72M |
| EBIT | -6.76M |
| Earnings Per Share (EPS) | -0.06 |
Balance Sheet
The company has 3.26M in cash and 349.05K in debt, giving a net cash position of 2.91M.
| Cash & Cash Equivalents | 3.26M |
| Total Debt | 349.05K |
| Net Cash | 2.91M |
| Retained Earnings | -128.05M |
| Total Assets | 9.8M |
| Working Capital | 5.54M |
Cash Flow
In the last 12 months, operating cash flow was -2.92M and capital expenditures 0, giving a free cash flow of -2.92M.
| Operating Cash Flow | -2.92M |
| Capital Expenditures | n/a |
| Free Cash Flow | -2.92M |
| FCF Per Share | -0.04 |
Margins
Gross margin is 100%, with operating and profit margins of -105.01% and -73.25%.
| Gross Margin | 100% |
| Operating Margin | -105.01% |
| Pretax Margin | -73.25% |
| Profit Margin | -73.25% |
| EBITDA Margin | -104.43% |
| EBIT Margin | -105.01% |
| FCF Margin | -45.38% |
Dividends & Yields
MLSS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for MLSS is $1.25, which is 13.6% higher than the current price. The consensus rating is "Hold".
| Price Target | $1.25 |
| Price Target Difference | 13.6% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Jan 14, 2004. It was a backward split with a ratio of 1:3.
| Last Split Date | Jan 14, 2004 |
| Split Type | backward |
| Split Ratio | 1:3 |
Scores
| Altman Z-Score | -7.39 |
| Piotroski F-Score | 2 |